Juan Carlos Porres Cubero

Juan Carlos Porres Cubero

Auto-generated profile, based on publicly available information

Juan Carlos Porres Cubero

Department of Gastroenterology, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2004 in Clinical Science
Verified
Journal Article
Open access
PDF file
MEMarta Escribano-Burgos
Marta Escribano-Burgos
ALAntonio López-Farré
Antonio López-Farré
MGMaría del Mar González
María del Mar González
CMCarlos Macaya
Carlos Macaya
AGAntonio García-Méndez
Antonio García-Méndez
JCJuan Carlos Porres Cubero
Juan Carlos Porres Cubero
The major CRP (C-reactive protein) receptor on leucocytes has been identified as the low-affinity IgG receptor Fcγ receptor II (CD32). Our aim was to assess whether inflammation may modify the presence of the CD32 receptor in BAEC (bovine aortic endothelial cells). Confocal microscopy experiments showed a weak expression of the CD32 receptor in control BAEC that was slightly increased by 10 μg/ml CRP. Incubation of BAEC with TNF-α (tumour necrosis factor-α) did not modify the fluorescence signal of CD32. Addition of CRP to TNF-α-incubated BAEC enhanced the fluorescence signal of the CD32 receptors. The CD32 receptors showed a perinuclear cytoplasmic localization in BAEC. An alteration of the NO (nitric oxide)-dependent vasorelaxation has been defined as endothelial dysfunction. Endothelial dysfunction has been associated with the presence of superoxide anion and with a reduction in the expression of the eNOS (endothelial NO synthase). A concentration of CRP similar to that detected in patients with cardiovascular risk (10 μg/ml) failed to modify the generation of superoxide anion stimulated by TNF-α. Western blot experiments showed that TNF-α decreased the expression of the eNOS protein, which was partially protected by treatment with 10 μg/ml CRP. The protective effect of 10 μg/ml CRP on eNOS expression in TNF-α-incubated BAEC was prevented by an antibody against CD32 receptors. In conclusion, the present results suggest that, although CRP has been associated with inflammation, CRP may protect the expression of eNOS protein against pro-inflammatory mediators such as TNF-α.

16 August 2023 in Medicina
Verified
Journal Article
Open access
PDF file
ALAdriana Ortega Larrode
Adriana Ortega Larrode
SFSergio Farrais
Sergio Farrais
CMCLAUDIA GUERRERO MUÑOZ
CLAUDIA GUERRERO MUÑOZ
LJLeonardo Blas Jhon
Leonardo Blas Jhon
MRMaria Jesus Martin Relloso
Maria Jesus Martin Relloso
JCJuan Carlos Porres Cubero
Juan Carlos Porres Cubero
We present the case of a 62-year-old patient who developed melenas and in whom conventional endoscopic tests could not detect any bleeding lesion. In our case, capsule endoscopy and enteroscopy were the pivotal elements in establishing the diagnosis of a neuroendocrine tumour with an atypical location. As a result, it was possible to surgically remove the lesions at an early stage of the malignancy without metastatic disease and without the need for adjuvant therapy. Our case demonstrates the need for these new techniques in tumours of atypical location and aggressive course. Otherwise, this malignancy may be underdiagnosed until an advanced stage.